Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation.
Dhir A, Hayashi M, Bodlak A, Oesterheld J, Loeb DM, Mascarenhas L, Isakoff MS, Sandler ES, Borinstein SC, Trucco M, Lagmay JP, Setty BA, Pratilas CA, Caywood E, Metts J, Yin H, Fridley B, Yin J, Laborde J, Reed DR, Adams DL, Wagner LM. Dhir A, et al. Among authors: laborde j. Clin Cancer Res. 2024 Dec 2;30(23):5314-5322. doi: 10.1158/1078-0432.CCR-24-1339. Clin Cancer Res. 2024. PMID: 39360936 Clinical Trial.
The decolonization dilemma at different stages of the academic career.
Rivera-Núñez T, Arcadia AL, Contreras-Mora A, Ratoni B, Echavarría Domínguez EU, Rivera-Núñez IM, Rubiano Guzmán MJ, Lugo-Castilla SL, Ruelas Inzunza E, Villalobos F, Laborde J, Martínez-Gómez JE, Merçon J, Boege K, Dáttilo W. Rivera-Núñez T, et al. Among authors: laborde j. Nat Ecol Evol. 2024 Sep;8(9):1559-1560. doi: 10.1038/s41559-024-02489-3. Nat Ecol Evol. 2024. PMID: 39009850 No abstract available.
Pathogenic Roles for RNASET2 in Clear Cell Renal Cell Carcinoma.
Peak T, Tian Y, Patel A, Shaw T, Obermayer A, Laborde J, Kim Y, Johnson J, Stewart P, Fang B, Teer JK, Koomen J, Berglund A, Marchion D, Francis N, Echevarria PR, Dhillon J, Clark N, Chang A, Sexton W, Zemp L, Chahoud J, Wang L, Manley B. Peak T, et al. Among authors: laborde j. Lab Invest. 2024 May;104(5):102041. doi: 10.1016/j.labinv.2024.102041. Epub 2024 Feb 29. Lab Invest. 2024. PMID: 38431116
Osimertinib vs. afatinib as first-line treatment for patients with metastatic non-small cell lung cancer with an EGFR exon 19 deletion or exon 21 L858R mutation.
Gilardone S, Thapa R, Laborde J, Shafique M, Saltos A, Creelan B, Tanvetyanon T, Chiappori A, Simon G, Haura EB, Gray JE, Chen DT, Melzer D, Pellini B. Gilardone S, et al. Among authors: laborde j. J Thorac Dis. 2023 Nov 30;15(11):6115-6125. doi: 10.21037/jtd-23-686. Epub 2023 Nov 8. J Thorac Dis. 2023. PMID: 38090314 Free PMC article.
225 results